Ia-2-ac

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Antibodies against tyrosine phosphatase IA2; Antibodies against tyrosine phosphatase IA-2; Anti-IA-2-Ac; anti-IA-2 antibodies; IA-2 antibody; Tyrosine phosphatase IA-2-Ak

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Anti-IA-2-Ak are antibodies that play a role in the differentiation of diabetes. They are directed against an islet cell membrane protein (ICA512, tyrosine phosphatase IA-2). At 60-80%, IA-2-Ak are slightly less frequently positive for type 1 diabetes than islet cell or GAD65 antibodies.

Anti-IA-2 antibodies are positive in 60-70% of type 1 diabetics and in 2-5% of first-degree relatives in first-degree diabetics. Of these antibody carriers, 65% develop diabetes mellitus within 5 years.

ImplementationThis section has been translated automatically.

Anti-IA2 antibody is detected by an enzyme linked immunosorbent assay (ELISA) using recombinant human tyrosine phosphatase (IA2) for its quantitative and qualitative determination.

Sample volume: > 75 µL serum

Reference range: < 10 IU/ml

Material: 1 ml serum

Note(s)This section has been translated automatically.

Anti-IA2 antibodies and GAD antibodies rarely occur simultaneously, so that antibody determinations complement each other.

Authors

Last updated on: 29.10.2020